The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.

Document Type

Journal Article

Publication Date

2-14-2021

Journal

The Oncologist

DOI

10.1002/onco.13713

Comments

Online ahead of print

Peer Reviewed

1

Find in your library

Share

COinS